You have 9 free searches left this month | for more free features.

Long term follow up

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

(LTFU) of Patients Treated With Genome-edited Autologous

Not yet recruiting
  • Sickle Cell Disease
  • OTQ923
  • (no location specified)
Nov 24, 2023

Knee Osteoarthritis Who Had Administered FURESTEM-OA Kit Inj. in

Not yet recruiting
  • Knee Osteoarthritis
    • (no location specified)
    Aug 28, 2023

    Long Term Follow up in Pediatric Supracondylar Humeral Fracture

    Not yet recruiting
    • Supracondylar Humerus Fracture
    • Elbow Fracture
      • (no location specified)
      Mar 20, 2023

      Titanium Modular Revision Hip System, With Review of Metal Ion

      Not yet recruiting
      • Hip Surgery
      • x-ray
      • (no location specified)
      Sep 11, 2023

      Cancer Survivor, Prostate Carcinoma Trial in Duarte (Educational Intervention, Laboratory Biomarker Analysis, Long-term

      Active, not recruiting
      • Cancer Survivor
      • Prostate Carcinoma
      • Educational Intervention
      • +4 more
      • Duarte, California
        City of Hope Medical Center
      Jan 31, 2023

      Dietary Intervention to Stop Coronary Atherosclerosis in

      Enrolling by invitation
      • Coronary Artery Disease
      • +2 more
      • DISCO Intervention
      • Warszawa, Poland
        National Institute of Cardiology
      Sep 6, 2023

      Long-term Follow-up of RESTORE Study

      Enrolling by invitation
      • Cancer
      • Long-term follow-up of cerena™
      • Long-term follow-up of attune™
      • San Francisco, California
        Blue Note Therapeutics
      Dec 9, 2022

      Long Term Follow-Up for RGX-111

      Enrolling by invitation
      • Mucopolysaccharidosis I
      • No Intervention
      • Orange, California
      • +2 more
      Oct 25, 2023

      A Long-Term Follow-Up Study of Participants Exposed to REACT

      Not yet recruiting
      • Diabetic Kidney Disease
      • Chronic Kidney Diseases
      • Renal Autologous Cell Therapy (REACT)
      • (no location specified)
      Jun 15, 2023

      Patient With Anti-GABAbr Antibodies Associated-encephalitis.

      Completed
      • Autoimmune Encephalitis
      • Long-term outcome
      • Lyon, France
        Centre de référence des syndromes neurologiques paranéoplasiques
      Feb 14, 2023

      Long Term Follow-up of the TREOCAPA Study (TREOCAPA-LT)

      Not yet recruiting
      • Patency of the Ductus Arteriosus Acetaminophen Extreme Prematurity
      • 2 year follow-up of neurodevelopment using a parental questionnaire
      • (no location specified)
      Sep 26, 2023

      HIV Trial (CAB LA)

      Not yet recruiting
      • HIV Infections
      • CAB LA
      • (no location specified)
      Nov 21, 2023

      Study of Participants Previously Enrolled in the STARLIGHT Study

      Enrolling by invitation
      • Stargardt Disease
      • Gene Therapy Product-MCO-010
      • Miami, Florida
      • +1 more
      Sep 15, 2023

      Using Phase-resolved Functional Lung MRI in COVID-19

      Recruiting
      • Pulmonary Function
      • Functional lung MRI
      • Beijing, Beijing, China
        Beijing Chaoyang Hospital
      Jul 5, 2023

      Long Term Efficacy and Safety Trial (Imlifidase administered in the 20-HMedIdeS-19 (PAES) study, Best available treatment

      Not yet recruiting
      • Long Term Efficacy and Safety
      • Imlifidase administered in the 20-HMedIdeS-19 (PAES) study
      • Best available treatment administered in the 20-HMedIdeS-19 (PAES) study
      • (no location specified)
      Jun 30, 2023

      l Gene Editing Therapy for Cardiovascular Disease

      Not yet recruiting
      • Atherosclerotic Cardiovascular Disease
      • +2 more
        • Auckland, New Zealand
        • +2 more
        Oct 31, 2023

        Patients With Inflammatory Disorders

        Enrolling by invitation
        • Inflammation
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 25, 2023

          Chikungunya Virus Infection Trial (PXVX0317 vaccine booster, Placebo booster)

          Not yet recruiting
          • Chikungunya Virus Infection
          • PXVX0317 vaccine booster
          • Placebo booster
          • (no location specified)
          Aug 18, 2023

          T-GENVIH-003 LTFU (Long Term Follow Up) Study

          Not yet recruiting
          • Hernia
          • +3 more
          • Integra® Gentrix® Surgical Matrix
          • Fort Myers, Florida
            Surgical Healing Arts
          Sep 12, 2023

          After Adoptive Transfer of Genetically Modified Cell Products

          Recruiting
          • Relapsed Hematologic Malignancy
          • Refractory Hematologic Malignancy
            • Memphis, Tennessee
              St. Jude Children's Research Hospital
            Feb 6, 2023

            Long-Term Follow-Up of Survivors of Pediatric Cushing Disease

            Recruiting
            • Cushing Disease
              • Bethesda, Maryland
                National Institutes of Health Clinical Center
              Feb 2, 2023

              Study of Subjects Who Received ICM-203 or Matching Placebo

              Not yet recruiting
              • Osteoarthritis, Knee
              • ICM-203
              • Placebo
              • Adelaide, South Australia, Australia
              • +1 more
              Feb 21, 2023

              Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)

              Enrolling by invitation
              • Kidney Transplant Rejection
              • End Stage Renal Disease
              • Urine sample
              • +2 more
              • Leuven, Belgium
              • +5 more
              Aug 3, 2023

              Long-term Follow-up Study of COVID-19

              Recruiting
              • COVID-19
                • Wuhan, Hu Bei Province, China
                • +1 more
                Aug 8, 2023

                Long Term Follow-up on Menkes Disease Patients

                Enrolling by invitation
                • Menkes Disease
                • Long Term Follow-Up
                • New York, New York
                  Cyprium Study Team
                Jul 14, 2022